| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.008 |